Collateral for a security interest recorded Aug 5, 2025 (JPMorgan Chase Bank, N.A.).
Term ends Jan 8, 2035 · High confidence
20-year base term ends Jan 8, 2035
Held by Adma Biomanufacturing, LLC
Filed Jan 8, 2015 as application 14/592,727 · Granted Nov 14, 2017
Base term plus 31 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2015
2035
Clock starts
Jan 8, 2015
Jan 8, 2015
Term ends
Jan 8, 2035
Jan 8, 2035
Granted
Nov 14, 2017
Nov 14, 2017
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
31
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 9,107,906, US 9,714,283.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 31 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 8, 2015, when this application, 14/592,727, was filed | Jan 8, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +31 days, USPTO patent term adjustment record | Feb 8, 2035 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,107,906, US 9,714,283) | capped to Jan 8, 2035 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 8, 2035 | High confidence |
This family
| Application 62/069,589 | Provisional application no patent term | no patent term |
| US 9,107,906 | In force Jan 2035 | Jan 2035 |
| US 9,815,886 | this patent Jan 2035 | Jan 2035 |
| US 9,714,283 | In force Jan 2035 | Jan 2035 |
| Application PCT/US2015/057715 | PCT application no patent term | no patent term |
| US 9,969,793 | In force Jan 2035 | Jan 2035 |
| US 10,683,343 | In force Jan 2035 | Jan 2035 |
| US 11,339,206 | In force Jan 2035 | Jan 2035 |
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 19, 2015 Reel 34987, frame 955 | Grossman, Adam S.; Mond, James; Grossman, Jerrold B. | Adma Biologics, Inc. | Assignment of Assignor's Interest |
| Oct 20, 2015 Reel 36835, frame 448 | Goldstein, Dov A. | Adma Biologics, Inc. | Assignment of Assignor's Interest |
| Nov 7, 2017 Reel 44057, frame 738 | Adma Biologics, Inc. | Wilmington Trust, National Association | Security Interest |
| Feb 12, 2019 Reel 48308, frame 913 | Wilmington Trust, National Association | Adma Biologics, Inc.; Adma Plasma Biologics, Inc.; Adma Bio Centers Georgia Inc.; Adma Biomanufacturing, LLC | Release of Intellectual Property Security Interest |
| Feb 12, 2019 Reel 48309, frame 289 | Adma Biologics, Inc. | Perceptive Credit Holdings II, LP | Security Interest |
| Feb 12, 2019 reel/frame not recorded | Wilmington Trust, National Association | Adma Biologics, Inc. | Release of Intellectual Property Security Interest |
| Feb 12, 2019 reel/frame not recorded | Wilmington Trust, National Association | Adma Plasma Biologics, Inc. | Release of Intellectual Property Security Interest |
| Feb 12, 2019 reel/frame not recorded | Wilmington Trust, National Association | Adma Bio Centers Georgia Inc. | Release of Intellectual Property Security Interest |
| Feb 12, 2019 reel/frame not recorded | Wilmington Trust, National Association | Adma Biomanufacturing, LLC | Release of Intellectual Property Security Interest |
| Mar 27, 2020 Reel 52252, frame 41 | Adma Biologics, Inc. | Perceptive Credit Holdings II, LP | Patent Security Agreement |
| Mar 23, 2022 Reel 59376, frame 718 | Adma Biologics, Inc. | Hayfin Services LLP | Security Interest |
| Mar 24, 2022 Reel 59383, frame 690 | Perceptive Credit Holdings II, LP, as Administrative Agent | Adma Biologics, Inc.; Adma Biomanufacturing, LLC | Release of Security Interest |
| Mar 24, 2022 reel/frame not recorded | Perceptive Credit Holdings II, LP, as Administrative Agent | Adma Biologics, Inc. | Release of Security Interest |
| Mar 24, 2022 reel/frame not recorded | Perceptive Credit Holdings II, LP, as Administrative Agent | Adma Biomanufacturing, LLC | Release of Security Interest |
| Apr 6, 2022 Reel 59515, frame 150 | Adma Biologics, Inc. | Adma Biomanufacturing, LLC | Assignment of Assignor's Interest |
| Dec 18, 2023 Reel 65898, frame 709 | Adma Biomanufacturing, LLC | Ares Capital Corporation, As Collateral Agent | Security Interest |
| Feb 29, 2024 Reel 66609, frame 108 | Hayfin Services LLP | Adma Biologics, Inc.; Adma Biomanufacturing, LLC | Release of Security Interest |
| Feb 29, 2024 reel/frame not recorded | Hayfin Services LLP | Adma Biologics, Inc. | Release of Security Interest |
| Feb 29, 2024 reel/frame not recorded | Hayfin Services LLP | Adma Biomanufacturing, LLC | Release of Security Interest |
| Aug 5, 2025 Reel 71930, frame 600 | Adma Biomanufacturing, LLC; Adma Biologics, Inc. | Jpmorgan Chase Bank, N.a. | Security Interest |
| Aug 5, 2025 Reel 71942, frame 191 | Ares Capital Corporation | Adma Biomanufacturing, LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2035
Term ends Jan 8, 2035. Maintenance fees still fall due before then
Note
The 31 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 9,107,906, US 9,714,283.
Citations
17
later US patents cite this one
That is top 25% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.